|
1
|
A new tumor-specific variant of GRP78 as target for antibody-based therapy.
|
Lab Invest
|
2008
|
1.42
|
|
2
|
Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans.
|
Cancer Res
|
2003
|
1.15
|
|
3
|
Lipoptosis: tumor-specific cell death by antibody-induced intracellular lipid accumulation.
|
Cancer Res
|
2004
|
1.07
|
|
4
|
High level expression of functional human IgMs in human PER.C6 cells.
|
MAbs
|
2009
|
1.02
|
|
5
|
The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoprotein.
|
Mol Cancer Ther
|
2007
|
1.01
|
|
6
|
Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients.
|
Hum Antibodies
|
2002
|
0.89
|
|
7
|
Human antibody SC-1 reduces disseminated tumor cells in nude mice with human gastric cancer.
|
Oncol Rep
|
2005
|
0.83
|
|
8
|
Neoadjuvant therapy of gastric cancer with the human monoclonal IgM antibody SC-1: impact on the immune system.
|
Oncol Rep
|
2008
|
0.80
|
|
9
|
Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1.
|
Cancer Res
|
2003
|
0.79
|
|
10
|
PAM-1, a natural human IgM antibody as new tool for detection of breast and prostate precursors.
|
Hum Antibodies
|
2004
|
0.77
|
|
11
|
Diagnostic and therapeutic potential of a human antibody cloned from a cancer patient that binds to a tumor-specific variant of transcription factor TAF15.
|
Cancer Res
|
2010
|
0.76
|